Project: dissection
1734 significantly associated models · 237 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 133358665 | 134912264 | 4 | 1 | 9.6e-08 | 6.2e-07 | 0.45515 | 98 | Idh2 |
2 | 1 | 149857704 | 156065975 | 48 | 7 | 9.2e-11 | 1.5e-09 | 1.00000 | 100 | Alg8 Aamdc B3gnt6 P4ha3 Fam168a Mogat2 NA |
3 | 1 | 251351727 | 260518987 | 47 | 5 | 7.0e-51 | 1.9e-51 | 1.00000 | 100 | Cacul1 Tectb AABR07007032.1 NA NA |
4 | 3 | 45415084 | 46813656 | 1 | 1 | 1.8e-07 | 1.2e-06 | 0.30060 | 95 | Tank |
5 | 3 | 88764368 | 94152740 | 38 | 6 | 6.4e-15 | 6.7e-14 | 1.00000 | 100 | Pax6 AABR07053185.1 Mpped2 Pdhx Hipk3 Ccdc73 |
6 | 3 | 126323673 | 128707024 | 6 | 1 | 1.8e-10 | 4.4e-12 | 0.00066 | 76 | AABR07054000.1 |
7 | 3 | 129554891 | 132898674 | 17 | 5 | 2.1e-20 | 2.3e-20 | NaN | NaN | Snrpb2 Pcsk2 Sec23b Scp2d1 NA |
8 | 6 | 19271415 | 20658264 | 1 | 1 | 3.0e-07 | 1.3e-08 | 0.00169 | 69 | Rasgrp3 |
9 | 6 | 20965724 | 29090273 | 71 | 9 | 2.0e-32 | 1.0e-32 | 1.00000 | 100 | Zfp513 Klhl29 Ehd3 Mapre3 Slc35f6 Dtnb Efr3b Dnmt3a NA |
10 | 7 | 110658552 | 112133640 | 2 | 2 | 2.2e-07 | 4.3e-08 | 0.60411 | 99 | Nptxr Apobec3 |
11 | 10 | 92666462 | 94065985 | 1 | 1 | 1.7e-07 | 1.3e-07 | 0.00032 | 54 | Cep112 |
12 | 10 | 103916742 | 105312647 | 1 | 1 | 3.1e-07 | 3.4e-07 | 1.00000 | 100 | Slc26a11 |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 31 | 1.46 | 3.4 |
Adipose | alternative TSS | 7 | 0.43 | 2.7 |
Adipose | gene expression | 91 | 1.10 | 3.2 |
Adipose | isoform ratio | 34 | 1.20 | 3.1 |
Adipose | intron excision ratio | 21 | 0.72 | 3.0 |
Adipose | mRNA stability | 37 | 1.07 | 3.3 |
BLA | alternative polyA | 11 | 0.92 | 3.2 |
BLA | alternative TSS | 11 | 1.31 | 3.7 |
BLA | gene expression | 64 | 1.06 | 3.4 |
BLA | isoform ratio | 19 | 1.08 | 3.0 |
BLA | intron excision ratio | 36 | 1.21 | 3.3 |
BLA | mRNA stability | 21 | 1.04 | 3.3 |
Brain | alternative polyA | 18 | 0.90 | 3.3 |
Brain | alternative TSS | 16 | 0.93 | 3.3 |
Brain | gene expression | 96 | 1.06 | 3.3 |
Brain | isoform ratio | 25 | 0.79 | 3.2 |
Brain | intron excision ratio | 51 | 0.94 | 3.2 |
Brain | mRNA stability | 50 | 1.15 | 3.4 |
Eye | alternative polyA | 2 | 1.12 | 3.3 |
Eye | alternative TSS | 4 | 1.67 | 3.9 |
Eye | gene expression | 13 | 1.16 | 3.4 |
Eye | isoform ratio | 5 | 1.41 | 2.9 |
Eye | intron excision ratio | 4 | 0.65 | 2.7 |
Eye | mRNA stability | 3 | 1.29 | 3.6 |
IL | alternative polyA | 3 | 0.49 | 2.9 |
IL | alternative TSS | 1 | 0.35 | 3.0 |
IL | gene expression | 34 | 0.93 | 3.3 |
IL | isoform ratio | 8 | 1.01 | 3.3 |
IL | intron excision ratio | 17 | 1.76 | 3.6 |
IL | mRNA stability | 18 | 1.62 | 3.5 |
LHb | alternative polyA | 5 | 0.87 | 3.3 |
LHb | alternative TSS | 3 | 0.86 | 3.1 |
LHb | gene expression | 41 | 1.28 | 3.5 |
LHb | isoform ratio | 10 | 1.33 | 3.4 |
LHb | intron excision ratio | 22 | 2.14 | 3.6 |
LHb | mRNA stability | 20 | 1.93 | 3.8 |
Liver | alternative polyA | 17 | 1.13 | 3.2 |
Liver | alternative TSS | 22 | 1.45 | 3.4 |
Liver | gene expression | 73 | 1.02 | 3.3 |
Liver | isoform ratio | 33 | 1.38 | 3.4 |
Liver | intron excision ratio | 49 | 1.12 | 3.2 |
Liver | mRNA stability | 29 | 1.18 | 3.4 |
NAcc | alternative polyA | 5 | 0.96 | 3.1 |
NAcc | alternative TSS | 7 | 2.04 | 3.6 |
NAcc | gene expression | 46 | 1.40 | 3.6 |
NAcc | isoform ratio | 6 | 0.81 | 3.1 |
NAcc | intron excision ratio | 12 | 1.26 | 3.3 |
NAcc | mRNA stability | 23 | 2.13 | 3.7 |
NAcc2 | alternative polyA | 12 | 1.08 | 3.4 |
NAcc2 | alternative TSS | 5 | 0.68 | 3.3 |
NAcc2 | gene expression | 65 | 1.22 | 3.4 |
NAcc2 | isoform ratio | 18 | 1.17 | 3.3 |
NAcc2 | intron excision ratio | 31 | 1.17 | 3.1 |
NAcc2 | mRNA stability | 24 | 1.34 | 3.6 |
OFC | alternative polyA | 13 | 2.23 | 4.2 |
OFC | alternative TSS | 0 | 0.00 | 3.5 |
OFC | gene expression | 52 | 1.40 | 3.4 |
OFC | isoform ratio | 11 | 1.35 | 3.3 |
OFC | intron excision ratio | 17 | 1.69 | 3.4 |
OFC | mRNA stability | 23 | 2.13 | 4.0 |
PL | alternative polyA | 9 | 1.50 | 3.6 |
PL | alternative TSS | 8 | 2.59 | 4.3 |
PL | gene expression | 41 | 1.10 | 3.3 |
PL | isoform ratio | 7 | 0.80 | 3.3 |
PL | intron excision ratio | 19 | 1.82 | 3.8 |
PL | mRNA stability | 23 | 2.00 | 4.0 |
PL2 | alternative polyA | 14 | 1.11 | 3.3 |
PL2 | alternative TSS | 7 | 0.75 | 3.3 |
PL2 | gene expression | 71 | 1.11 | 3.4 |
PL2 | isoform ratio | 21 | 1.14 | 3.2 |
PL2 | intron excision ratio | 39 | 1.24 | 3.2 |
PL2 | mRNA stability | 30 | 1.23 | 3.5 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.